Gilead, Galapagos slide after FDA rejects filgotinib over toxicity concerns
August 19, 2020 at 12:28 PM EDT
Mizuho sees the news as a "clear positive" for both AbbVie and Pfizer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
